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Validation and human factor analysis study
of an infant weight estimation device
Susan M. Abdel-Rahman1,2* , Ian M. Paul3, Paula Delmore4, Jia-Yuh Chen5, Mary Mills6, Rachel G. Greenberg6 and
on behalf of the Best Pharmaceuticals for Children Act – Pediatric Trials Network
Abstract
Background: Weight is critical for the medical management of infants; however, scales can be unavailable or
inaccessible in some practice settings. We recently developed and validated a robust infant weight estimation
method based on chest circumference (CC) and head circumference (HC). This study was designed to determine
the human factors (HF) experience with, and predictive performance of, an infant weight estimation device that
implements this method.
Methods: Prospective, multi-center, observational, masked study of 486 preterm and term infants (0–90 days)
assessed by 15 raters. Raters measured the infant using calibrated scales/measures and masked versions of the
device. Raters also evaluated critical tasks associated with device use. Mean error (ME) and mean percentage error
(MPE) were used to assess predictive performance.
Result: Among 486 infants enrolled (36.8 ± 4.0 weeks gestational age, 31.5 ± 28.6 days postnatal age), predicted
weight correlated highly with actual weight (r = 0.97, ME: − 69 ± 257 g, MPE: − 1.3 ± 6.9%). Predicted weight was
within 10 and 15% of actual weight in 86 and 99%, of infants. HF errors were low, 0.1–0.8% depending on task. In
all cases raters were confident or very confident in their measurements.
Conclusion: The device was statistically equivalent to the method on which it was based and approximated
weight with acceptable variance from the true weight. HF data suggest the device is easy to use. This device can
be used to estimate weight in infants when calibrated scales are impractical or unavailable.
Keywords: Chest circumference, Head circumference, Preterm, Full-term

Background
Body weight is the foremost marker of health and health
outcomes during infancy. It is essential for evaluating
growth and development and is a critical factor in safe
and effective medical management throughout childhood [1–3]. A calibrated weighing scale remains the universal gold standard for obtaining weight in children;
however weighing scales are often not available in
resource-constrained settings across the globe [4–8].
Where scales are available, it can still be challenging to
remove or account for the weight of life-sustaining medical equipment prior to obtaining a scale-based weight.
* Correspondence: srahman@cmh.edu
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Numerous proxies for weight in the newborn have been
investigated; however, the majority of studies are
designed to identify thresholds that discriminate low
birth weight newborns [9]. In response to the need for a
simple, robust weight estimation strategy, we developed
a method for estimating weight in infants from the circumference of the head and chest [10]. The method was
based on a similar approach developed previously for
weight estimation in children [11], and the resultant
prototype (Mercy babyTAPE) is a variation on the U.S.
Food and Drug Administration cleared pediatric device
(MercyTAPE). (https://www.accessdata.fda.gov/scripts/
cdrh/cfdocs/cfpmn/pmn.cfm?ID=K142469).
The final element of a risk management process designed
to reduce design-related problems that contribute to unsafe
or ineffective use of a medical device is human factors
validation testing. For devices that represent a modification
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of a device already on the market, the risk analysis is expected to focus on aspects of the device that were affected
by the modification including the users’ interactions with
the device [12]. The primary objectives of our study were to
examine the critical tasks for the safe and effective operation of the babyTAPE in a device use environment and
confirm the predictive performance of the babyTAPE when
applied by end-users. Secondary aims of the study were to
define inter-rater reliability for the babyTAPE and capture
users’ subjective experience with the device.

Materials/subjects and methods
Study design

This was a prospective, multi-center, observational study
conducted in the outpatient clinics and inpatient newborn units at three U.S. hospitals (Children’s Mercy,
Kansas City, MO; Hershey Medical Center, Hershey, PA;
Wesley Medical Center, Wichita, KS).
Device

Details surrounding the method on which the babyTAPE
device (i.e. the study device) is based have been previously published [10]. The babyTAPE device is a flexible,
paper-based strip printed on both sides with one side
(yellow) designated for head circumference measurements and the other (blue) designated for chest circumference measurement (Fig. 1). The “start” end on each
side of the device is marked with a large contrasting triangle. Along the length of the babyTAPE are 1 cm (cm)
“bins” of alternating color that have additional markings
which correspond to fractional weight values. The estimated weight of the infant (in hundredths of a kilogram)
is obtained by summing the fractional weights derived
from the two measurements. Since raters had knowledge
of the infant’s weight, a masked version of the device
replaced fractional weight values with arbitrary alphanumeric characters to minimize the potential for bias.
The characters were organized so that we could discern
whether the correct side and the correct starting end of
the investigational device were used to perform the
measurements. The code was broken only after enrollment closed at all participating sites. Study devices
were printed on paper, and checked against a National
Institute of Standards and Technology (NIST)-certified
ruler in compliance with International Organization for
Standardization (ISO) 9000 standards.

Fig. 1 Mercy babyTAPE (not drawn to scale)

Page 2 of 8

Participant infants

All infants presenting to the participating institutions of
any gestational age who were 0–90 days of life were
eligible for enrollment. Infants were stratified into 9
postmenstrual age blocks to ensure balanced enrollment
and an even distribution of participants across weight
and length. Participants were excluded if there were
known or apparent anatomical deformities, external
medical equipment that would impair the determination
of actual weight, if they were incapable of having the
measurements performed, or if the investigator or treating physician perceived contraindications to their inclusion. All infants were enrolled with informed parental
permission under a protocol that was reviewed and approved by the Institutional Review Boards of the respective study sites.
Participant raters

Study raters were required to qualify for participation by
demonstrating accuracy and reproducibility measuring
head- and chest-circumference. Prospective raters made
three sets of non-sequential measurements on three
infant sized mannequins using a standard tape measure
and the babyTAPE. Pre-study training was provided to
ensure that the raters could identify the correct anatomic landmarks and read a standard tape measure.
However, specific training on application of the babyTAPE was not provided. Rather, raters were provided with
the babyTAPE “Instructions for Use” (Additional file 1)
and evaluated according to their ability to execute the
measurements based on these instructions. Intra-rater
variance was calculated for each rater and could not
exceed 5% for any measurement. Raters that failed qualification were remediated and given the opportunity to
repeat the qualification. Raters that failed the second
qualification were not be permitted to participate in the
study.
Measurements

At enrollment we recorded participants’ gestational age,
postnatal age, sex, race, and ethnicity. Weight was determined using a calibrated infant scale after removing
clothing and diapers. Length was obtained using standard medical equipment available in patient care areas of
the participating institution. Circumferential measures
(in millimeters) were performed with a standard vinyl
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tape measure that was checked against an NIST-certified
ruler. Chest circumference was determined with the
infant’s arms extended outward to shoulder level and
the tape measure placed under the axilla and around the
chest, passing by the xyphoid process at the level of the
nipple. Every effort was made to record chest circumference at the end of exhalation. To obtain head circumference, the tape measure was placed around the infant’s
head so that it lay across the frontal bones, slightly above
the eyebrows and ears, over the occipital prominence at
the back of the head, perpendicular to the long axis of
the face. The same technique for measuring head and
chest circumference was applied for both the standard
tape measure and the babyTAPE. All measurements
were performed at the same time by a single rater.
Approximately 10% of participants at each site were
selected for multi-rater assessment to examine interrater reliability. After completion of measurements,
infants were observed for an additional 10 min to assess
study-related adverse device effects (ADEs).
After performing all study-related measures, subjective
assessments of the babyTAPE were provided by each
rater for each enrolled child via the following questions:
Did you have any trouble identifying the proper landmarks on the infant? Could you correctly identify the
proper starting ends of the babyTAPE for the measurements? Did you experience any difficulty performing the
measurements on this infant with the babyTAPE? Were
the circumference markings on the babyTAPE easy for
you to read? Using the same babyTAPE you just used,
how confident are you that you would obtain the same
readings if you repeated them right now on the same
infant?

Data analysis

Three critical tasks were defined a priori: 1) identification of the correct anatomic landmarks, 2) proper
use and orientation of the device, and 3) accurate
observation and recording of the device outputs.
Critical task #1 was examined by determining
whether recorded chest and head circumferences
measured using the babyTAPE were within the
expected range for each participant’s age and weight.
Chest circumference measurements were compared
to reference data collected in a published anthropometric study [13]. Head circumference measurements
were compared to the Center for Disease Control
and Prevention-National Health and Nutrition Examination Survey reference data [14]. Absolute z-scores
of > 3 were classified as extreme outliers and examined for a possible misidentification of anatomical
landmarks in conjunction with the infants z-score
for length and weight.
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Critical task #2 was examined by determining whether
measurements recorded for the babyTAPE and reference
tape were concordant. Reference tape measurements
were binned to the nearest centimeter before evaluation.
Discrepancies of ≥3 bins were identified as indicative of
errors with the measurement and/or recording of reference tape or babyTAPE-values. In these cases, the estimated weight assigned by each device was evaluated in
an attempt to identify the clinical significance of the
erroneous measurement.
Critical task #3 was examined by determining whether
recorded values for babyTAPE circumferences measurements appeared on the device as printed and appeared
on the side of the device indicated by the user. The
number and percentage of measurements with observation or recording errors were summarized.
The predictive performance of the babyTAPE was
established by comparing the babyTAPE predicted
weights with weights measured on a calibrated medical
scale. The difference between these measurements were
summarized using statistics that include the mean error,
mean squared error, and proportion within 10 and 15%
of actual weight. Parameter estimates and 95% confidence intervals were compared with results found from
the validation study of the method that the babyTAPE
embodies.
Between-user variability was examined by comparing
the babyTAPE and reference tape circumference measures from the multi-rater assessment. Between-user
variability was characterized through estimation of the
intraclass correlation coefficient (ICC), the accompanying 95% confidence intervals, and the proportion of
observations ≥10% apart. Agreement between estimated
weight and actual weight was determined using BlandAltman plots with log-transformation. IBM SPSS version
24 (IBM Corp., Armonk, NY) and SAS (version 9.3, SAS
Institute, Inc., Cary, NC) were used for all analyses.
Sample size calculation

Sample size was estimated based on the ability to
discriminate device-estimated weight from actual weight.
Assuming an observed proportion of estimated weights
that differ from actual weight by ≤10% of 0.8, a twosided 95% Wilson’s score confidence interval is (0.76,
0.83) with 460 participants after accounting for dropouts. Additionally, selection of at least 50 participants
for multi-rater assessment provides > 80% power to
conclude that the ICC is > 0.8 when the true ICC is 0.9.

Results
In total, 486 participants were enrolled across the three
clinical study sites. For these infants, gestational age
averaged 36.8 ± 4.0 weeks and postnatal age 31.5 ± 28.6
days (Fig. 2). Participants were 52% male; 62% were
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Fig. 2 Histograms depicting the study population distribution for gestational age (left), postnatal age (center), and weight (right). Grey areas
depict overlap of preterm and full-term infants

white, 24% were black, and 22% were Hispanic or Latino.
The distribution of weight across the population ranged
from 682 to 7590 g as depicted in Fig. 2 along with the
distribution of the other anthropometric parameters.
With respect to habitus, weight-for-length z-scores
ranged from − 3.5 to 3.7 with 133 infants under the 5th
%tile, 300 between the 5th and 84th %tile, 39 between
the 85th and 95th %ile, and 14 above the 95th %ile.
Seventeen raters participated in the training; 15 who
passed on their first attempt and 2 who passed after
remediation; however, only 15 participated in the study.
Across the study, no ADEs were reported.
No child was excluded for anthropometric measurements outside of the expected range for age and gender
(Critical task #1). For the objective determination of the
potential for human error with this device, measurement
differences of > 3 cm between the babyTAPE and reference tape were examined. The data revealed that 0.6% of
the 972 total babyTAPE measurements were discordant
with the measurements made using the reference tape
(Critical task #2). These were comprised of 6 measurements in 4 children performed by 3 raters (Table 1). In
each case, the error (as reflected by the impact on estimated weight) appears to have been with the reference

tape measure rather than the babyTAPE device. Application of the weight estimation method using a reference
tape measure resulted in percentage error ranging from
− 12.2 to 18.4% and absolute percent error greater than
or equal to 5% in all participants. In contrast, weight
estimation by the babyTAPE in these infants resulted in
percentage error ranging from − 1.4 to 2% and absolute
percent error ≤ 2% in all participants. In no case was
the incorrect side or incorrect end of the device used
(Critical task #3).
A total of 36 participants were selected for multi-rater
measures. The ICC for chest circumference and head
circumference measured using the babyTAPE were 1.00
(1.00, 1.00). For measurements made with a reference
tape measure the ICC for chest circumference was 0.99
(0.99, 1.00) and head circumference was 1.00 (0.99,
1.00). In no case was the auditor-derived measurement
≥10% different from the rater-derived measurements.
For head circumference, rater and auditor measures differed in the range of − 0.5 to 0.6 cm (− 1.69 to 1.74%).
Chest circumference measures varied from − 1.6 to 1.4
cm (− 4.42 to 4.38%).
Subjective perceptions of the critical human factors
tasks are described as follows. Of 972 total measurements,
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Table 1 Measurement errors uncovered as part of the human factors analysis in 486 infants
Rater

Discordant
Measure

EGA

PNA

Actual weight
(kg)

Reference est. wt.
(kg)

Reference error
(%)

babyTAPE est. wt.
(kg)

babyTAPE error
(%)

1

CC, HC

38 wk., 3 d

19 d

3.335

3.75

12.4%

3.31

−0.75%

4

CC, HC

40 wk., 0 d

53 d

3.970

4.17

5.0%

4.05

2.0%

12

HC

41 wk., 3 d

70 d

5.526

4.85

−12.2%

5.48

−0.8%

12

CC

41 wk., 1 d

29 d

4.534

5.37

18.4%

4.47

−1.4%

CC Chest circumference, d days, EGA Estimated gestational age, est. wt. estimated weight, HC Head circumference, kg kilograms, PNA Postnatal age, wk weeks

only one rater indicated difficulty in identifying the proper
anatomic landmarks for the chest in one participant. No
other raters expressed difficulty with identifying landmarks in the head and chest. In two and six cases, respectively (0.2 and 0.6% of measurements), raters indicated
difficulty identifying the proper starting end of the device
or reading the markings on the device. Finally, raters
expressed difficulty making the chest measurement in five
children and the head measurement in three children.
Overall, 100% of raters were confident or very confident
of obtaining the same readings if repeated immediately on
the same infant.

There was substantial agreement between the infants’
actual weight and the device predicted weight (Fig. 3,
Additional file 2: Figure S1). The regression slope (confidence interval, CI) was 0.96 (95% CI 0.94, 0.98) with an
intercept of 0.076 (95%CI 0.03, 0.12). Exploring the
magnitude of this deviation reveals a mean error of −
69 ± 257 g corresponding to a mean percentage error of
− 1.3 ± 6.9%. There was also strong agreement between
the infants’ actual weight and the method from which
the babyTAPE device was developed (Fig. 3, Additional
file 2: Figure S1). For this regression the slope was 0.95
(95% CI 0.94, 0.97), the intercept 0.113 (95%CI 0.07,

Fig. 3 Scatterplot depicting the concordance between actual weight and device-estimated weight (upper) or method estimated weight (lower)
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0.16), the mean error − 66 ± 249 g, and the mean
percentage error − 1.1 ± 7.1%. The fraction of infants in
whom the babyTAPE device predicted weight within 10
and 15% of actual weight was 0.86 and 0.99, respectively.

Discussion
Several devices have been described for classifying
newborns as “low birth weight” based on measures of
chest circumference, thigh circumference, upper-arm
circumference, or foot length [15–18]. To our knowledge, however, there are no devices that facilitate the
estimation of kilogram weight in infants. In a previous study we developed a method for weight estimation in infants through the first 90 days of life [10]. In
this study, a prototype device based on this method
was applied by representative end-users to pediatric
patients in a device use environment. In support of
an anticipated regulatory submission for device clearance, the primary objective of this study was to establish whether the babyTAPE could be used safely and
effectively in the intended population.
Overall the babyTAPE slightly under predicted weight
as evidenced by a mean error, mean percentage error,
and regression slope of − 69 g, − 1.3%, and 0.96, respectively. With respect to predictive performance, the babyTAPE appears to be statistically equivalent to the
method on which it was based and the device approximates infant weights with acceptable variance from the
true weight. With 86% of infants in this study predicted
within 10% of actual and 99% predicted within 15% of
actual, the babyTAPE is actually slightly more robust
than the MercyTAPE evaluated using the same trial
design, in which 76 and 98% of children were predicted
within 10 and 20% of their actual weight, respectively
[19]. This is likely explained because the babyTAPE was
developed for a much narrower age band (0–90 days)
than the predecessor device, which was designed for
children 2 months to 16 years of age. We also speculate
that the anatomic measures selected for the babyTAPE
are easier for the users to perform. Though still reproducibly obtained, the ICC for measures used by the MercyTAPE, namely humeral length and mid-upper arm
circumference, are slightly lower than observed for head
circumference and chest circumference (0.94 [0.92,0.96]
for both measures) [13].
Collectively, challenges experienced with any of the critical tasks (i.e. identification of the correct anatomic landmarks, proper use and orientation of the device, accurate
observation and recording of the device outputs) occurred
at a rate of < 1%. There were also no instances in which the
user did not feel confident or highly confident with their
measurements. These subjective perceptions imply that
users find the babyTAPE easy to use. This is reflected in
the objective data wherein we observed only 6 instances in
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4 patients where the babyTAPE and the standard tape measure were inconsistently applied. Notably, in each of the 4
cases, the error appears to have been with the reference tape
measure rather than the babyTAPE device. This is not the
first time we have experienced an issue with health care providers having trouble using and/or accurately reading values
from a tape measure [20, 21]. In fact, it is one factor that
plays a role in the failure of raters to qualify for participation
in our anthropometric studies. Consequently, the use of a
binning strategy on the babyTAPE, where singular values
span 1 cm blocks, may play a role in mitigating problems
that arise when practitioners are trying to read a reference
tape measure with discrete 1 mm intervals.
We would be remiss not to highlight the limitations of this
study. Participating raters were required to demonstrate proficiency in performing head and chest circumference measurements. This may not reflect the skills of the provider
using the device in a clinical setting and thus could overestimate performance of the device. However, none of the raters
in this study represented neonatal clinicians who may have
greater familiarity with these measurements in this population. Nevertheless, the accompanying instruction sheet was
created in an attempt to provide the necessary education.
The study also enrolled children who were stable enough to
have measurements performed. As a result, we are unable to
comment on the ability to use the device effectively in unstable, critically ill-infants. Finally, the number of children enrolled under 30 weeks of gestation was low and additional
experience may be required to inform of usability challenges
at the lower extreme of age.

Conclusions
To our knowledge, the Mercy babyTAPE represents the
first device that has been successfully validated for accurate
weight estimation of preterm and term newborns. Though
the end users will have to determine whether the predictive
performance of the babyTAPE is suitable for their indication, the data presented herein support the assertion that
the babyTAPE can be reliably, reproducibly, and comfortably used by trained providers to estimate weight in young
infants when calibrated scales are unavailable.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12887-020-1933-5.
Additional file 1. Mercy babyTAPE Instructions for Use.
Additional file 2. Supplemental Figure, Bland-Altman plots depicting
the difference between device-predicted weight versus actual weight
(upper), method-predicted weight versus actual weight (middle), and
device-predicted weight versus method-predicted weight (lower). Dashed
lines depict the 95% limits of agreement.
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